Literature DB >> 11805779

Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases.

Rafik A Abdelsayed1, Ty Sumner, Carl M Allen, Antwan Treadway, Gregory M Ness, Sam L Penza.   

Abstract

The development of secondary malignancies has been recognized as a potential iatrogenic complication in patients who have graft-versus-host disease secondary to bone marrow transplantation. Lymphohematopoietic cancer is most frequent, although solid malignancies have also been reported. We describe 2 patients with graft-versus-host disease who developed oral precancerous and malignant lesions. The first patient, a 24-year-old white man, had erythroplakia of the buccal mucosa that proved to be carcinoma in situ histopathologically. The second patient, a 14-year-old Hispanic boy, developed synchronous cutaneous and lingual squamous cell carcinomas. The current cases and similar sporadic case reports found in the literature highlight the susceptibility of patients with graft-versus-host disease to the development of oral cancer. Therefore, it is recommended that thorough evaluation of the oral mucosa and close follow-up be offered to all patients treated with bone marrow transplantation and particularly to those who develop graft-versus-host disease.

Entities:  

Mesh:

Year:  2002        PMID: 11805779     DOI: 10.1067/moe.2002.119736

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  6 in total

1.  Squamous cell carcinoma associated with chronic graft versus host disease-like/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab.

Authors:  Adepitan A Owosho; Joseph Randazzo; Evan B Rosen; Cherry L Estilo; Joseph M Huryn; Ping Chi; SaeHee K Yom
Journal:  Oral Oncol       Date:  2016-10-13       Impact factor: 5.337

2.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

Review 3.  Dental treatment in patients with leukemia.

Authors:  Caroline Zimmermann; Maria Inês Meurer; Liliane Janete Grando; Joanita Ângela Gonzaga Del Moral; Inês Beatriz da Silva Rath; Silvia Schaefer Tavares
Journal:  J Oncol       Date:  2015-02-15       Impact factor: 4.375

4.  Two Lip Carcinomas following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Nouha Dammak; Latifa Berrezouga; Manel Njima; Ines Lahouel; Mehdi Khemiss; Mohamed Ben Khelifa
Journal:  Int J Dent       Date:  2021-08-27

5.  Repeated Occurrence and Recurrence of Secondary Oral Solid Cancers after Hematopoietic Stem Cell Transplantation for Leukaemia: Long-Term Follow-Up.

Authors:  Takumi Takahashi; Miki Yamada; Keisuke Sawada; Nami Nakayama; Yosuke Iijima; Shunsuke Hino; Takahiro Kaneko; Norio Horie
Journal:  Case Rep Dent       Date:  2022-08-22

Review 6.  Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years.

Authors:  Astrid L D Kruse; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2009-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.